Part 5: FDA VRBPAC Presentation – October 22, 2020

This is Part 5 of a 9-part series showcasing the evidentiary findings related to the official Renz Law COVID-19 investigation.

Part 5 consists of a Presentation from the FDA’s VRBPAC, which stands for “Vaccines and Related Biological Products Advisory Committee”, which took place in October of 2020.  This presentation shows categories of expected side effects which were never disclosed to the public, as well as a list of data sources that are being withheld from public disclosure.

Share now!

You cannot copy content of this page